A nasal spray that contains esketamine — a potent derivative of ketamine — can now be taken on its own to treat adults with ...

I’ve been living with depression for almost 12 years. I’m 31 now and I found out I had major depressive disorder when I was 19. I had a miserable freshman year of college, but I didn't really ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

The Food and Drug Administration (FDA) approved Johnson & Johnson’s ketamine-derived nasal spray to help millions of U.S.

Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...

The largest, most ethnically diverse, study of its kind has flagged hundreds of genetic variants that play a role in ...

Takeda is taking back the home license for a phase 3-stage depression drug as part of an amendment to its multi-asset ...

Neurocrine Biosciences advances Phase 3 plans for osavampator after achieving Phase 2 success in major depressive disorder, amending its Takeda deal.

Biochemical analyses provide an answer to the question of how the gut bacterium Morganella morganii might contribute to some ...

People with treatment-resistant depression can now take Spravato's ketamine-derived nasal spray as a standalone treatment.

NeuroStar is committed to advancing the body of scientific research and elevating mental health treatment through robust research and data-driven innovation,” stated Keith J. Sullivan, President and ...